dual PI3K/mTOR inhibitor (PIQUR Therapeutics)

N/A

Report date: 2025/03/18 18:12:08
NME

Base Information

Drug Namedual PI3K/mTOR inhibitor (PIQUR Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsPI3-kinase class ISerine/threonine-protein kinase mTOR
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPiqur Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesPiqur Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A